Actuate Therapeutics
Total Raised
$72.6MInvestors Count
6Deal Terms
1Funding, Valuation & Revenue
11 Fundings
Actuate Therapeutics has raised $72.6M over 11 rounds.
Actuate Therapeutics's latest funding round was a IPO for $22.4M on August 13, 2024.
Actuate Therapeutics's latest post-money valuation is from August 2024.
Sign up for a free demo to see Actuate Therapeutics's valuations in August 2024 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
8/13/2024 | IPO | $22.4M | 4 | |||
3/5/2024 | Debt - IV | $3M | Undisclosed Investors | 1 | ||
10/19/2022 | Series C | $19.33M | 2 | |||
12/10/2020 | Series B - III | |||||
10/15/2019 | Series B - II |
Date | 8/13/2024 | 3/5/2024 | 10/19/2022 | 12/10/2020 | 10/15/2019 |
|---|---|---|---|---|---|
Round | IPO | Debt - IV | Series C | Series B - III | Series B - II |
Amount | $22.4M | $3M | $19.33M | ||
Investors | Undisclosed Investors | ||||
Valuation | |||||
Revenue | |||||
Sources | 4 | 1 | 2 |
Actuate Therapeutics Deal Terms
1 Deal Term
Actuate Therapeutics's deal structure is available for 1 funding round, including their IPO from August 13, 2024.
Round | IPO |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO |
Actuate Therapeutics Investors
6 Investors
Actuate Therapeutics has 6 investors. Kairos Ventures invested in Actuate Therapeutics's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
5/13/2019 | 10/19/2022 | 4 Series B, Series B - II (2019), Series B - III (2020), Series C (2022) | Venture Capital | California | ||
Venture Capital | California | |||||
Venture Capital | Texas | |||||
Angel Investor (Group) | California | |||||
Venture Capital | California |
First funding | 5/13/2019 | ||||
|---|---|---|---|---|---|
Last Funding | 10/19/2022 | ||||
Investor | |||||
Rounds | 4 Series B, Series B - II (2019), Series B - III (2020), Series C (2022) | ||||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Venture Capital | Angel Investor (Group) | Venture Capital |
Location | California | California | Texas | California | California |
Loading...